Nuvation Bio Inc. (NUVB)

Nuvation Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	10.96	7.87	-	-	-	-
Cost of Revenue	9.17	7.08	-	-	-	-
Gross Profit	1.79	0.8	-	-	-	-
Selling, General & Admin	97.27	69.23	28.53	31.92	24.28	10.95
Research & Development	110.88	99.12	71.29	87.82	65.25	32.6
Operating Expenses	208.15	168.35	99.82	119.73	89.53	43.55
Operating Income	-206.36	-167.56	-99.82	-119.73	-89.53	-43.55
Interest Expense	-0.4	-0.34	-	-	-	-
Interest & Investment Income	25.25	27.06	24.61	7.45	2.96	1.95
Other Non Operating Income (Expenses)	0.2	-2.02	-0.45	9.32	3.59	-0.27
EBT Excluding Unusual Items	-181.3	-142.86	-75.66	-102.97	-82.98	-41.88
Gain (Loss) on Sale of Investments	-0.01	-0.01	-0.14	-1.23	-0.08	0.22
Pretax Income	-606.38	-567.94	-75.8	-104.2	-86.85	-41.66
Net Income	-606.38	-567.94	-75.8	-104.2	-86.85	-41.66
Net Income to Common	-606.38	-567.94	-75.8	-104.2	-86.85	-41.66
Shares Outstanding (Basic)	299	269	219	217	198	98
Shares Outstanding (Diluted)	299	269	219	217	198	98
Shares Change (YoY)	36.40%	22.79%	1.00%	9.52%	102.90%	-52.81%
EPS (Basic)	-2.03	-2.11	-0.35	-0.48	-0.44	-0.43
EPS (Diluted)	-2.03	-2.11	-0.35	-0.48	-0.44	-0.43
Free Cash Flow	-157.55	-130.58	-68.07	-96.48	-68.47	-36.67
Free Cash Flow Per Share	-0.53	-0.49	-0.31	-0.45	-0.35	-0.38
Gross Margin	16.29%	10.10%	-	-	-	-
Operating Margin	-1883.38%	-2128.25%	-	-	-	-
Profit Margin	-5534.21%	-7213.76%	-	-	-	-
Free Cash Flow Margin	-1437.85%	-1658.52%	-	-	-	-
EBITDA	-205.43	-166.87	-99.6	-119.54	-89.35	-43.45
D&A For EBITDA	0.94	0.68	0.22	0.2	0.18	0.1
EBIT	-206.36	-167.56	-99.82	-119.73	-89.53	-43.55

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q